A comparison of ovulation suppression and ovulation stimulation in the treatment of endometriosis-associated infertility

other OA: closed public-domain-us
View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This study found similar pregnancy rates among infertile endometriosis patients treated with ovulation stimulation (clomiphene) or suppression (danazol), with clomiphene showing a higher likelihood of pregnancy than expectant therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This study compares ovulation stimulation or suppression with the pregnancy rate among infertile couples with endometriosis. The design is a nonrandomized, prospective, multicentered cohort analytic study. Two hundred and ninety-seven couples with laparoscopy-proven endometriosis were analyzed: 68 received no therapy, 42 received clomiphene and 74 received danazol. Forty patients (22%) conceived and pregnancy rates were similar in each treatment group. The relative likelihood of pregnancy associated with clomiphene was 2.9 (95% confidence limits 1.2-7.1); the relative likelihood of pregnancy with danazol was 1.02 (95% confidence limits 0.5-2.3). This study suggests that pregnancy rates during clomiphene treatment could be superior to expectant therapy, while pregnancy rate after danazol is similar to no treatment.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Clomiphene Danazol Endometriosis Infertility, Female Ovulation Induction Pregnancy Uterine Neoplasms Adult Clomiphene Clomiphene Cohort Studies Danazol Danazol Endometriosis Endometriosis Female Humans Infertility, Female Infertility, Female Male

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-26T06:15:21.694264+00:00
pubmed
last seen: 2026-05-13T22:11:49.821429+00:00
unpaywall
last seen: 2026-09-26T06:30:31.687879+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine